發(fā)布時間：2018-01-17 17:03

  本文關(guān)鍵詞：補腎醒腦法對2型糖尿病認(rèn)知功能障礙小鼠性激素信號通路相關(guān)激素水平、海馬Erα和ErβmRNA的影響研究　出處：《成都中醫(yī)藥大學(xué)》2016年博士論文　論文類型：學(xué)位論文

  更多相關(guān)文章： 2型糖尿病 認(rèn)知功能障礙 補腎醒腦法 性激素 Erα和Erβ mRNA

【摘要】：本論文分為2型糖尿病(Type 2 Diabetes Mellitus T2DM)認(rèn)知功能障礙與性激素信號通路相關(guān)性的理論探討和科學(xué)研究兩部分。第一部分理論探討從祖國醫(yī)學(xué)的角度出發(fā),結(jié)合導(dǎo)師觀點和自身研究,對消渴呆病(糖尿病認(rèn)知功能障礙)的定義、病因病機、辨證論治和現(xiàn)代醫(yī)學(xué)研究進(jìn)行簡要闡述。第二部分科學(xué)研究目的：研究2型糖尿病小鼠性激素信號通路中下丘腦-垂體-性腺軸(Hypothalamic-pituitary-gonadal axis HPG)中相關(guān)激素水平、海馬中Er α和Er β mRNA水平的表達(dá),進(jìn)而明確補腎醒腦法改善2型糖尿病認(rèn)知功能障礙小鼠的認(rèn)知能力與其對性激素信號通路某些環(huán)節(jié)的調(diào)控的相關(guān)性。方法：健康清潔級雌性8周齡昆明小鼠,為正常對照組；健康SPF級(specific pathogen free無特定病原體級)雌性8周齡KKay小鼠為實驗組。KKay小鼠,經(jīng)去勢手術(shù)和糖尿病認(rèn)知功能障礙成模檢測成功后隨機分為模型對照組、陽性對照組、中藥組和中藥去勢組(中藥去勢組先行去卵巢手術(shù))。陽性對照組予吡拉西坦；中藥組、中藥去勢組予醒腦益智合劑；KKay小鼠糖尿病造模成功后均予羅格列酮常規(guī)控制血糖。給藥周期共計8周。在糖尿病成模后和給藥結(jié)束后分別各進(jìn)行一次Morris水迷宮實驗。第二次水迷宮實驗結(jié)束后,及時于冰上進(jìn)行實驗動物解剖及樣本制備。酶聯(lián)免疫分析法(Enzyme linked immunosorbent assay ELISA)檢測各組小鼠相關(guān)性激素水平；實時熒光定量聚合酶鏈?zhǔn)椒磻?yīng)(Quantitative Real-time Polymerase Chain Reaction QRT-PCR)測定海馬中雌激素受體1 (Estrogen receptor Er a)和雌激素受體2 (Estrogen receptor Er β)mRNA的表達(dá)。結(jié)果：(1)第一次水迷宮實驗結(jié)果中正常對照組和各組糖尿病小鼠平臺潛伏期比較,各組均明顯偏高(P0.05),可見T2DM小鼠認(rèn)知能力顯著低于正常小鼠。去卵巢后小鼠和其他各組小鼠比較P0.05,說明去勢后急速衰老的T2DM小鼠認(rèn)知能力顯著低于正常小鼠和壯年的T2DM小鼠。第二次水迷宮實驗結(jié)果中正常對照組和模型對照組、中藥去勢組的小鼠比較P0.05,說明這兩組的認(rèn)知能力顯著低于正常對照組。給藥前后比較：中藥去勢組、陽性對照組和中藥組水迷宮成績第二次都明顯好于第一次(P0.05),即經(jīng)吡拉西坦治療后T2DM小鼠和醒腦益智合劑治療后的T2DM小鼠、去勢的T2DM小鼠認(rèn)知能力均明顯提高。(2)在HPG軸性激素水平研究中發(fā)現(xiàn)：模型對照組E2、P水平顯著低于正常組(P0.05)。模型對照組、陽性對照組、中藥去勢組的LH、FSH、PRL水平顯著高于正常組(P0.05),說明T2DM KKay小鼠、陽性對照組和急速衰老T2DM KKay小鼠的LH、FSH、PRL出現(xiàn)紊亂。而T的變化不大,沒有明顯統(tǒng)計學(xué)差異。在經(jīng)過醒腦益智合劑治療后中藥組E2、P顯著高于模型對照組(P0.05)。中藥組和正常對照組,中藥去勢組與模型組E2、P、LH、FSH比較時P0.05,沒有明顯統(tǒng)計學(xué)差異,這說明使用醒腦益智合劑治療2型糖尿病認(rèn)知功能障礙KKay小鼠和其急速衰老小鼠模型是有效的,能調(diào)節(jié)HPG軸性激素的紊亂,糾正E2、P的低水平,降低LH、FSH的過高水平。(3)在小鼠海馬Er α和Er β mRNA的表達(dá)研究中：T2DM KKay小鼠和去勢的T2DM KKay小鼠Er α和Er β mRNA表達(dá)顯著低于正常水平(P0.05)；模型對照組和中藥組比較P0.05,有明顯統(tǒng)計學(xué)差異,模型對照組和中藥去勢組比較P0.05,沒有明顯統(tǒng)計學(xué)差異,說明經(jīng)醒腦益智合劑治療T2DM KKay小鼠和去勢T2DMKKay小鼠Er α和Er β mRNA表達(dá)能有所提高。中藥治療后T2DM KKay小鼠的Er α和Er β mRNA表達(dá)顯著高于模型對照組；治療后去勢T2DM KKay小鼠Er α和Er βmRNA表達(dá)升高接近模型對照組。陽性對照組和中藥去勢組、模型對照組Er α mRNA表達(dá)比較P0.05,有明顯統(tǒng)計學(xué)差異,說明吡拉西坦對小鼠Er α mRNA表達(dá)有一定影響,使Er α mRNA表達(dá)在一定程度上升高。模型對照組和陽性對照組Er β mRNA比較P0.05,沒有明顯統(tǒng)計學(xué)差異,說明吡拉西坦對T2DM小鼠Er β mRNA表達(dá)影響不大。結(jié)論：在常規(guī)控制血糖的基礎(chǔ)上,醒腦益智合劑能有效提高T2DM認(rèn)知功能障礙小鼠和去勢后急速衰老的T2DM認(rèn)知功能障礙小鼠的學(xué)習(xí)、記憶能力,其可能的作用機制可能是通過調(diào)整HPG性激素的水平,升高E2、P,降低LH、FSH;增強大腦海馬Er α和Er β mRNA水平的表達(dá)而達(dá)到的。
[Abstract]:This paper is divided into type 2 diabetes (Type 2 Diabetes Mellitus T2DM) cognitive theory and scientific research related dysfunction and sexual hormone signaling pathways of two parts. Starting from the perspective of traditional Chinese medicine combined with the first part of the theory, research ideas and their mentor cancellation, stay thirsty disease (diabetic cognitive dysfunction) definition, etiology machine, TCM and modern medicine research were briefly described. The second part of the scientific research objective: To study the type 2 diabetic mice sex hormone signaling in the hypothalamic pituitary gonadal axis (Hypothalamic-pituitary-gonadal axis HPG) in hormone levels, expression of hippocampal Er alpha and Er beta mRNA level, then clearly improve Bushenxingnao method the cognitive ability of type 2 diabetic mice with cognitive impairment on sex hormone signaling pathway in some segments of the control. Methods: healthy female 8 week old Kunming mice as normal control group; SPF (specific pathogen free healthy specific pathogen free) female 8 week old KKay mice to.KKay mice in the experimental group, after castration and diabetic cognitive dysfunction model after successful detection were randomly divided into model group, positive control group, Chinese medicine group and traditional Chinese medicine the ovariectomized group (Chinese medicine group first castrated ovariectomy). Positive control group treated with piracetam; traditional Chinese medicine group, Chinese medicine group received castration xinnaoyizhi Decoction; KKay mice rats were treated with rosiglitazone. The conventional control of blood glucose administration period a total of 8 weeks. After diabetic model and after medication respectively. The first Morris water maze test. The end of the second after the water maze test, in experimental animal anatomy and sample preparation on ice. Enzyme linked immunosorbent assay (Enzyme linked immunosorbent assay ELISA) to detect the small Correlation between hormone levels in rats; real-time fluorescence quantitative polymerase chain reaction (Quantitative Real-time Polymerase Chain Reaction QRT-PCR) determination of estrogen receptor in hippocampus (Estrogen 1 receptor Er a) and estrogen receptor 2 (Estrogen receptor Er) on the expression of mRNA. Results: (1) the first water maze test results in the normal control group and diabetic group platform mice incubation period between groups were significantly higher (P0.05), the cognitive ability of visible T2DM mice was significantly lower than that of normal mice. The ovariectomized mice and the mice in other groups compared with P0.05, said T2DM cognitive ability rapid aging Ming after castration was significantly lower than that of normal mice and T2DM mice. In the second water maze experiment results in normal control group and model control group, Chinese medicine group were castrated P0.05, illustrate the cognitive ability of the two groups were significantly lower than the control group. Before administration After comparison: Chinese medicine castration group, positive control group and Chinese medicine group water maze test second times better than the first time (P0.05), by Laci Staw after the treatment of T2DM mice and xingnaoyizhi mixture in the treatment of T2DM after castration mice, T2DM mice cognitive ability were significantly improved. (2) found in the study of sex hormones the HPG axis: the model control group E2, the level of P was significantly lower than that of normal group (P0.05). The model control group, positive control group, Chinese medicine LH FSH, castration group, PRL level was significantly higher than that of normal group (P0.05), T2DM KKay mice, positive control group and the rapid aging T2DM mice with KKay LH FSH. PRL and T disorders. Little change, no significant statistical difference. After xingnaoyizhi mixture after treatment in Chinese medicine group E2, P were significantly higher than the model group (P0.05). The Chinese medicine group and normal control group, Chinese medicine group and the ovariectomized model group E2, P, LH, FSH is P0.05, there is no clear Significant statistical difference, which shows that the use of xingnaoyizhi mixture in the treatment of type 2 diabetic cognitive dysfunction in KKay mice and the rapid aging mice model is effective and can regulate the HPG axis hormone disorder, correct E2, lower level, P LH, the high level of FSH. (3) the expression of alpha and Er in hippocampus of mice Er beta mRNA: T2DM KKay T2DM KKay mice and ovariectomized mice Er alpha and Er beta mRNA expression was significantly lower than the normal level (P0.05); model group and Chinese medicine group P0.05, there was significant difference in model control group and Chinese medicine castration group P0.05, no statistically significant difference, which shows that the effect of Xingnao Yizhi mixture the treatment of T2DM KKay mice and ovariectomized T2DMKKay mice Er alpha and Er beta mRNA expression can be increased. The expression of T2DM in mice after treatment with Chinese medicine KKay Er alpha and Er beta mRNA was significantly higher than that in the model control group; after treatment of ovariectomized female T2DM KKay mice Expression of Er alpha and Er beta mRNA increased to the model group. The positive control group and Chinese medicine castration group, model control group, Er mRNA expression of P0.05, there was significant difference that piracetam has a certain effect on the mice Er alpha mRNA expression, the Er expression of mRNA alpha high rise in a certain extent. The model control group and the positive control group Er beta mRNA P0.05, no significant difference, indicating piracetam has little effect on the T2DM expression of mouse Er beta mRNA. Conclusion: Based on conventional glucose control, Xingnao Yizhi mixture can effectively improve the T2DM cognitive dysfunction in mice after castration and rapidly aging T2DM cognitive dysfunction in mice's learning and memory ability. And the possible mechanism may be HPG by adjusting the level of sex hormones, increased E2, P, lower LH, FSH; enhance the expression of hippocampal Er alpha and Er beta mRNA level and to achieve.

【學(xué)位授予單位】：成都中醫(yī)藥大學(xué)
【學(xué)位級別】：博士
【學(xué)位授予年份】：2016
【分類號】：R259;R277.7

【相似文獻(xiàn)】

相關(guān)期刊論文 前10條

1 崔友強;滕良珠;李國新;龐琦;;ER、PCNA在老年泌乳素型垂體腺瘤中的表達(dá)及臨床意義[J];中國老年學(xué)雜志;2006年02期

2 龍漢安,肖秀麗,劉俊,唐學(xué)清,李世寧;乳腺浸潤性導(dǎo)管癌ER、PR表達(dá)的臨床病理意義[J];華西醫(yī)學(xué);2004年02期

3 劉春蓮;顧繼偉;彭亮;焦海燕;;CYP1B1 SNPrs1056836、ER和PR與寧夏漢族乳腺癌遺傳易感性研究[J];中國腫瘤;2009年01期

4 艾星子;卵巢子宮內(nèi)膜異位癥中ER-α、ER-βmRNA的表達(dá)特征[J];國外醫(yī)學(xué).婦產(chǎn)科學(xué)分冊;2001年02期

5 王蘋,陳怡君,吳黎雅,魏霖,李秀蘭;性激素水平與ER、PR的表達(dá)在乳腺增生病辨證分型中的意義[J];福建醫(yī)科大學(xué)學(xué)報;2005年03期

6 夏斌,姚裕家,陳娟,程開健;新生鼠實驗性缺氧缺血性腦損傷ER-α、IGF-1R的表達(dá)及雙重表達(dá)[J];四川大學(xué)學(xué)報(醫(yī)學(xué)版);2004年05期

7 陳小巖，林振石，唐秀如，，林劍英;90例乳腺良性病變組織中ER和PR的表達(dá)[J];臨床與實驗病理學(xué)雜志;1996年02期

8 蔣紹仟;ER、PR染色中消除內(nèi)源性過氧化物酶方法的改良[J];四川腫瘤防治;2001年03期

9 趙丕文;牛建昭;王繼峰;王玲巧;;異補骨脂素和蛻皮甾酮對人乳腺癌T47D細(xì)胞增殖及ER亞型表達(dá)的影響[J];北京中醫(yī)藥大學(xué)學(xué)報;2007年04期

10 胡強,商希鋒,任子善,周健,王宏利;免疫組化法測定小兒隱睪睪丸周圍組織AR,ER的意義[J];濰坊醫(yī)學(xué)院學(xué)報;2003年02期

相關(guān)會議論文 前10條

1 于少英;安廣朋;圖雅;;~(154)Er核三軸超形變核態(tài)存在的微觀機制[A];第十二屆全國核物理大會論文集（上）[C];2004年

2 王蘋;陳怡君;胡勵軍;;性激素水平與ER、PR的表達(dá)在乳腺增生病辨證分型中的意義[A];第十一屆全國中醫(yī)及中西醫(yī)結(jié)合乳腺病學(xué)術(shù)會議論文集[C];2009年

3 陳琦;譚布珍;高國蘭;豐穎;胡輝;;HOXA11及ER在人良、惡性子宮內(nèi)膜增生組織中的表達(dá)及意義[A];中國抗癌協(xié)會婦科腫瘤專業(yè)委員會第十一屆全國學(xué)術(shù)會議論文匯編[C];2011年

4 劉志勇;;ER抗摩擦金屬調(diào)理劑在寶鋼自備電廠的應(yīng)用[A];第六屆全國摩擦學(xué)學(xué)術(shù)會議論文集（下冊）[C];1997年

5 鄭元章;趙立芬;郭萍敬;葉文凌;黃祖賢;李加龍;王建林;;ER-α在雙峰駝下丘腦-垂體-卵巢軸的表達(dá)[A];中國畜牧獸醫(yī)學(xué)會動物解剖學(xué)及組織胚胎學(xué)分會第十七次學(xué)術(shù)研討會論文集（下）[C];2012年

6 陳雨金;黃藝東;羅遵度;;硼酸鉍玻璃中Er~(3+)和Yb~(3+)的光譜特性[A];第五屆中國功能材料及其應(yīng)用學(xué)術(shù)會議論文集Ⅰ[C];2004年

7 孫慧;張靜;戰(zhàn)忠利;郝希山;;ER-β與其信號傳導(dǎo)通路中相關(guān)基因在不同乳腺癌模型發(fā)展中的時空變化[A];中華醫(yī)學(xué)會病理學(xué)分會2006年學(xué)術(shù)年會論文匯編[C];2006年

8 孫慧;張靜;戰(zhàn)忠利;郝希山;;ER-β與其信號傳導(dǎo)通路中相關(guān)基因在不同乳腺癌模型發(fā)展中的時空變化[A];第四屆中國腫瘤學(xué)術(shù)大會暨第五屆海峽兩岸腫瘤學(xué)術(shù)會議論文集[C];2006年

9 俞佳;楊玉林;范瑞清;楊玉林;;Er~(3+),Yb~(3+)共摻TiO_2上轉(zhuǎn)換粉體在染料敏化太陽能電池中的應(yīng)用[A];第十三屆全國光化學(xué)學(xué)術(shù)討論會論文集[C];2013年

10 廖伯琴;林辛未;;~(164)Er_(96)與~(166)Er_(98)核推轉(zhuǎn)殼模型波函數(shù)K結(jié)構(gòu)的討論[A];第八屆全國核物理會議文摘集（上冊）[C];1991年

相關(guān)重要報紙文章 前1條

1 ;H3C ER路由器軟件全面升級支持IPsec VPN[N];電腦商報;2008年

相關(guān)博士學(xué)位論文 前8條

1 李東東;NaYF_4:Yb~(3+),Er~(3+)上轉(zhuǎn)換納米顆粒的控制合成與多功能集成研究[D];東南大學(xué);2015年

2 張靜;補腎醒腦法對2型糖尿病認(rèn)知功能障礙小鼠性激素信號通路相關(guān)激素水平、海馬Erα和ErβmRNA的影響研究[D];成都中醫(yī)藥大學(xué);2016年

3 章靜;ER-α36和SOX4在ER陰性乳腺癌中的作用研究[D];浙江大學(xué);2012年

4 程倩;NaGdF_4:Yb~(3+)，Er~(3+)磁性—熒光納米粒子的制備及改性機理研究[D];哈爾濱工業(yè)大學(xué);2013年

5 張瑾;基于NaYF_4:Yb,Er多功能納米材料的制備及其特性研究[D];中國科學(xué)院研究生院(長春光學(xué)精密機械與物理研究所);2014年

6 佟敬山;ER-α 36在子宮內(nèi)膜癌中的功能及Icaritin誘導(dǎo)的細(xì)胞凋亡的研究[D];吉林大學(xué);2011年

7 張昌盛;離子注入摻Er富硅氧化硅材料研究[D];中國科學(xué)院研究生院（上海微系統(tǒng)與信息技術(shù)研究所）;2005年

8 黃愛華;宮瘤清含藥血清對子宮肌瘤細(xì)胞ER、PR、EGFR、IGF-1R及肌瘤細(xì)胞凋亡的實驗研究[D];成都中醫(yī)藥大學(xué);2005年

相關(guān)碩士學(xué)位論文 前10條

1 徐文明;NaYF_4:Yb~(3+)/Er~(3+)上轉(zhuǎn)換納米晶的制備及其生物探針應(yīng)用[D];福州大學(xué);2014年

2 徐樂;乳腺癌超聲圖像特征與ER、PR、CerbB-2的相關(guān)性研究[D];重慶醫(yī)科大學(xué);2016年

3 汪林瀟;同質(zhì)包覆及金納米體系對NaYF_4:Yb~(3+)/Er~(3+)納米顆粒的熒光調(diào)控效應(yīng)[D];陜西師范大學(xué);2016年

4 陳欣怡;COX-2、ER和PR的表達(dá)與乳腺癌生存率關(guān)系及其與HER-2基因的擴增關(guān)系[D];青島大學(xué);2010年

5 李飛濤;Er~（+3）摻雜TiO_2電極的染料敏化太陽能電池的性究[D];河南大學(xué);2011年

6 賈艷玲;Er，Cr:YSGG激光照射牙本質(zhì)對間接修復(fù)體使用的粘接劑性能影響的研究[D];福建醫(yī)科大學(xué);2012年

7 鄔彩靈;NaLuF_4:Yb,Er上轉(zhuǎn)換納米粒子的合成及其對HeLa細(xì)胞的標(biāo)記[D];東北大學(xué);2014年

8 李瓊珊;抑制素、ER、PR在子宮內(nèi)膜不典型增生中的表達(dá)及其臨床意義[D];蘇州大學(xué);2009年

9 廖本強;Er：YAG激光牙科治療儀設(shè)計與仿真[D];合肥工業(yè)大學(xué);2004年

10 王威;不同時間Er：YAG激光照射處理對牙本質(zhì)粘接強度的影響[D];山西醫(yī)科大學(xué);2013年

本文編號：1437133